Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ethical Dilemmas I01:17

Ethical Dilemmas I

Ethical dilemmas in nursing are of utmost importance, as they often arise from the tension between adhering to core ethical principles and the practical realities of healthcare delivery. These dilemmas require nurses to navigate complex situations where competing ethical considerations pull them in different directions.
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Ethical Issues01:27

Ethical Issues

Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychological wellness and health-related stigma: a pilot study of an acceptance-focused cognitive behavioural intervention for people with lung cancer.

European journal of cancer care·2014
Same author

Cassava latent virus infections mediated by the Ti plasmid of Agrobacterium tumefaciens containing either monomeric or dimeric viral DNA.

Plant molecular biology·2013
Same author

Motorcycles and breast cancer: the influence of peer support and challenge on distress and posttraumatic growth.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2011
Same author

Patient recall of tetanus immunization status.

Canadian family physician Medecin de famille canadien·2011
Same author

The Family Physician as Peacemonger: How to Talk to Your Patients about the Threat of Nuclear War.

Canadian family physician Medecin de famille canadien·2011
Same author

General practice in new zealand.

Canadian family physician Medecin de famille canadien·2011
Same journal

Impact of virtual case conferences between primary care clinicians and an interdisciplinary chronic pain clinic.

Canadian family physician Medecin de famille canadien·2026
Same journal

Canadian family physician Medecin de famille canadien·2026
Same journal

Predictors of high-performing family medicine clinics: Prospective cohort study in Alberta.

Canadian family physician Medecin de famille canadien·2026
Same journal

Acetylsalicylic acid use for artial fibrillation and bleeding risk.

Canadian family physician Medecin de famille canadien·2026
Same journal

Clinical practice guidelines: Important tools to teach the art of medicine.

Canadian family physician Medecin de famille canadien·2026
Same journal

Paratonia in advanced dementia: Challenges and evidence-based interventions.

Canadian family physician Medecin de famille canadien·2026
See all related articles

Related Experiment Video

Updated: Jun 5, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Neonatal screening part 3: controversial issues.

B A Morris

    Canadian Family Physician Medecin De Famille Canadien
    |January 15, 2011
    PubMed
    Summary
    This summary is machine-generated.

    This article explores future neonatal screening possibilities in Canada. It discusses screening for cystic fibrosis, hypercholesterolemia, sickle cell disease, and muscular dystrophy, which are not currently screened.

    More Related Videos

    State of the Art Cranial Ultrasound Imaging in Neonates
    10:02

    State of the Art Cranial Ultrasound Imaging in Neonates

    Published on: February 2, 2015

    Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
    06:15

    Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

    Published on: March 6, 2019

    Related Experiment Videos

    Last Updated: Jun 5, 2026

    Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
    19:15

    Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

    Published on: August 25, 2014

    State of the Art Cranial Ultrasound Imaging in Neonates
    10:02

    State of the Art Cranial Ultrasound Imaging in Neonates

    Published on: February 2, 2015

    Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
    06:15

    Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

    Published on: March 6, 2019

    Area of Science:

    • Medical Genetics
    • Public Health
    • Neonatal Care

    Background:

    • Neonatal screening is crucial for early detection of genetic diseases.
    • Previous articles covered general principles and current Canadian screening practices.
    • This article focuses on the future of neonatal screening in Canada.

    Purpose of the Study:

    • To examine controversial topics and potential future directions for neonatal screening in Canada.
    • To discuss specific diseases that could be included in future screening programs.

    Main Methods:

    • Review of current screening practices and emerging technologies.
    • Analysis of the feasibility and implications of screening for specific diseases.

    Main Results:

    • Identifies four diseases—cystic fibrosis, hypercholesterolemia, sickle cell disease, and muscular dystrophy—as potential candidates for expanded neonatal screening.
    • Highlights the controversial nature of expanding screening programs.

    Conclusions:

    • Expanded neonatal screening holds potential benefits but requires careful consideration of ethical, economic, and logistical factors.
    • Future screening decisions must balance early detection with resource allocation and societal impact.